rs62648096

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001271938.2(MEGF8):​c.5634C>T​(p.Arg1878Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00716 in 1,612,282 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0072 ( 50 hom. )

Consequence

MEGF8
NM_001271938.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.239

Publications

4 publications found
Variant links:
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
  • MEGF8-related Carpenter syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Carpenter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 19-42360920-C-T is Benign according to our data. Variant chr19-42360920-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473336.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.239 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00647 (986/152362) while in subpopulation AMR AF = 0.00738 (113/15310). AF 95% confidence interval is 0.00668. There are 6 homozygotes in GnomAd4. There are 536 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEGF8NM_001271938.2 linkc.5634C>T p.Arg1878Arg synonymous_variant Exon 32 of 42 ENST00000251268.11 NP_001258867.1 Q7Z7M0-1
MEGF8NM_001410.3 linkc.5433C>T p.Arg1811Arg synonymous_variant Exon 31 of 41 NP_001401.2 Q7Z7M0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEGF8ENST00000251268.11 linkc.5634C>T p.Arg1878Arg synonymous_variant Exon 32 of 42 5 NM_001271938.2 ENSP00000251268.5 Q7Z7M0-1
MEGF8ENST00000334370.8 linkc.5433C>T p.Arg1811Arg synonymous_variant Exon 31 of 41 1 ENSP00000334219.4 Q7Z7M0-2
MEGF8ENST00000378073.5 linkc.-1452C>T 5_prime_UTR_variant Exon 32 of 41 5 ENSP00000367313.4 F5GZG7
MEGF8ENST00000598762.1 linkc.-52C>T upstream_gene_variant 3 ENSP00000471370.1 M0R0Q0

Frequencies

GnomAD3 genomes
AF:
0.00648
AC:
986
AN:
152244
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00739
Gnomad ASJ
AF:
0.0233
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0191
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00720
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00794
AC:
1957
AN:
246608
AF XY:
0.00812
show subpopulations
Gnomad AFR exome
AF:
0.00119
Gnomad AMR exome
AF:
0.00546
Gnomad ASJ exome
AF:
0.0223
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0165
Gnomad NFE exome
AF:
0.00952
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.00724
AC:
10566
AN:
1459920
Hom.:
50
Cov.:
32
AF XY:
0.00723
AC XY:
5247
AN XY:
726044
show subpopulations
African (AFR)
AF:
0.00129
AC:
43
AN:
33458
American (AMR)
AF:
0.00592
AC:
264
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.0238
AC:
619
AN:
26056
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39674
South Asian (SAS)
AF:
0.00223
AC:
192
AN:
86094
European-Finnish (FIN)
AF:
0.0158
AC:
837
AN:
52936
Middle Eastern (MID)
AF:
0.0177
AC:
102
AN:
5754
European-Non Finnish (NFE)
AF:
0.00720
AC:
7999
AN:
1111036
Other (OTH)
AF:
0.00844
AC:
509
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
604
1209
1813
2418
3022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00647
AC:
986
AN:
152362
Hom.:
6
Cov.:
32
AF XY:
0.00719
AC XY:
536
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00168
AC:
70
AN:
41588
American (AMR)
AF:
0.00738
AC:
113
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0233
AC:
81
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4830
European-Finnish (FIN)
AF:
0.0191
AC:
203
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00720
AC:
490
AN:
68036
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00825
Hom.:
3
Bravo
AF:
0.00557
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 31, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEGF8: BP4, BP7, BS2 -

MEGF8-related Carpenter syndrome Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MEGF8-related disorder Benign:1
Jan 19, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
7.7
DANN
Benign
0.74
PhyloP100
0.24
PromoterAI
0.0035
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62648096; hg19: chr19-42865072; COSMIC: COSV52077410; COSMIC: COSV52077410; API